Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3691129 | 1.00 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL30320284 | 1.00 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL3696409 | 1.00 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL16356746 | 0.88 | TAAR1 (0.62) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL29067215 | 0.86 | TAAR1 (0.65) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL7307051 | 0.85 | CYP3A4 (0.63) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL4329251 | 0.84 | CYP3A4 (0.61) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL14377906 | 0.84 | CYP3A4 (0.61) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL7385509 | 0.84 | CYP3A4 (0.61) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL7118271 | 0.84 | TAAR1 (0.58) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109400573-B | Benzo [ d ] [1,3] dioxole compound, preparation method and application thereof | 中国人民解放军第二军医大学 | 2023-04-11 | — | — | CN | claimed |
| CN-109400573-A | Benzo [d] [1,3] dioxole class compound, preparation method and applications | 中国人民解放军第二军医大学 | 2019-03-01 | — | — | CN | claimed |
| CN-117897223-A | Plant protein-based microcapsules | 弗门尼舍有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117813154-A | Polyamide-based microcapsules | 弗门尼舍有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117715697-A | Microcapsules with mineral layer | 弗门尼舍有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117460573-A | Polyamide-based microcapsules | 弗门尼舍有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117377527-A | Polyamide-based microcapsules | 弗门尼舍有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-117202987-A | Microcapsules based on acetoacetyl polymers | 弗门尼舍有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-117157140-A | Coated core-shell microcapsules | 弗门尼舍有限公司 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | disclosed |
| CN-117098598-A | Crosslinked core-shell microcapsules | 弗门尼舍有限公司 | 2023-11-21 | — | — | CN | disclosed |
| EP-1858934-B1 | METALLOCENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2013-04-24 | — | — | EP | disclosed |
| WO-2010131274-A1 | PROCESS FOR PREPARING HYDROCINNAMIC ALDEHYDES IN ENANTIOPURE OR ENANTIOMERICALLY ENRICHED FORM | ENDURA S.P.A (IT) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010131274-A1 | PROCESS FOR PREPARING HYDROCINNAMIC ALDEHYDES IN ENANTIOPURE OR ENANTIOMERICALLY ENRICHED FORM | ENDURA S.P.A (IT) | 2010-11-18 | — | — | WO | disclosed |
| US-7803887-B2 | Metallocene compounds | BASELL POLYOLEFINE GMBH (DE) | 2010-09-28 | — | — | US | disclosed |
| US-20090221772-A1 | Bridged bis indenyl ligands where the indene ring is further fused to an oxygen or sulfur-containing ring, such as mu -{Bis-[ eta 5-8-(4-tert-butylphenyl)-6-methyl-5H-indeno[5,6-a][1,3]dioxol-5-yl]dimethylsilanediyl}dichlorozirconium; olefin polymerization catalysts; very high molecular weight | BASELL POLYLEFINE GMBH (DE) | 2009-09-03 | — | — | US | disclosed |
| EP-1858934-A1 | METALLOCENE COMPOUNDS | Basell Polyolefine GmbH (DE) | 2007-11-28 | — | — | EP | disclosed |
| WO-2006097500-A1 | METALLOCENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2006-09-21 | — | — | WO | disclosed |
| US-5599951-A | ENZYME INHIBITORS | SOCIETE CIVILE BIOPROJET (FR) | 1997-02-04 | — | — | US | disclosed |
| EP-0403158-A2 | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221772-A1 | Bridged bis indenyl ligands where the indene ring is further fused to an oxygen or sulfur-containing ring, such as mu -{Bis-[ eta 5-8-(4-tert-butylphenyl)-6-methyl-5H-indeno[5,6-a][1,3]dioxol-5-yl]dimethylsilanediyl}dichlorozirconium; olefin polymerization catalysts; very high molecular weight | LTC4S, HMOX1, OPRM1 | TAAR1 736/4885SLC6A4 4636/4885SLC6A2 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.